刺激性肠综合征患者BDI-II和HAMD-21的因子分析
Akaki Burkadze1, Eka Burkadze2, Tamar Kandashvili3
1Department of Psychiatry, Tbilisi State Medical University, 0186 Tbilisi, Georgia.
Alpha psychiatry
|July 9, 2025
概括
这项研究验证了格鲁吉亚IBS患者的贝克抑郁 inventory-II和汉密尔顿抑郁评分表,发现它们对评估抑郁症是互补的. 这两种尺度在这个人群中都表现出令人满意的因数有效性.
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 心理测量 心理测量 心理测量
背景情况:
- 刺激性肠综合征 (IBS) 经常与抑郁症状同时发生.
- 在IBS群体中,常见的抑郁症评估工具,贝克抑郁症目录II (BDI-II) 和汉密尔顿抑郁症评分表 (HAMD-21) 的因数有效性尚未确定.
- 了解这些尺度的心理特征对于IBS患者的准确诊断和治疗至关重要.
研究的目的:
- 在格鲁吉亚的IBS人口中评估BDI-II和HAMD-21的因数有效性.
- 分析IBS患者用这两种尺度测量抑郁症状之间的相互关系.
主要方法:
- 主要组件分析使用了89名IBS患者的数据.
- 用自身值≥1和因子负载>0.4与斜旋转来确定因子结构.
- 对因数有效性的测量包括凯泽-梅耶-奥尔金,克朗巴赫的α,巴特利特的测试,共同性和余数.
主要成果:
- 根据BDI-II和HAMD-21分数,该样本表现出中度抑郁症.
- 根据BDI-II的结果,BDI-II提供了三个因素,而HAMD-21则确定了四个因素.
- 在BDI-II和HAMD-21之间观察到强烈的正相关性 (r = 0.88,p = 0.000),大多数症状聚集在一个主要组件中.
结论:
- 在格鲁吉亚的IBS患者中,BDI-II和HAMD-21证明了令人满意的因数有效性,得到了高的内部一致性和组件相关性的支持.
- 这些发现表明,BDI-II和HAMD-21是评估IBS患者抑郁症状的可靠和互补工具.
- 这项研究强调了IBS和常见的抑郁症措施之间抑郁症症状的显著重叠.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
253
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
253
Irritable Bowel Syndrome I: Introduction
395
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
395
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
428
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
428
Irritable Bowel Syndrome III: Medical and Nursing Management
313
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
313
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Assessment of the Gastrointestinal System I: Subjective Data
289
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
289


